Buchumschlag

Oral idarubicin, dexamethasone and vincristine in the treatment of multiple myeloma: final analysis of a phase II trial

This prospective phase II study evaluated a regimen with vincristine, oral idarubicin and dexamethasone (VID) in 74 patients with multiple myeloma. A partial response was achieved in 57% (16/28) of patients with previously untreated disease and in 35% (16/46) with refractory diseases. VID chemothera...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Glasmacher, Axel (VerfasserIn) , Goldschmidt, Hartmut (VerfasserIn) , Mezger, Jörg (VerfasserIn) , Haferlach, Torsten (VerfasserIn) , Schmidt-Wolf, Ingo G. H. (VerfasserIn) , Gieseler, Frank (VerfasserIn)
Dokumenttyp: Article (Journal) Editorial
Sprache:Englisch
Veröffentlicht: 2004
In: Haematologica
Year: 2004, Jahrgang: 89, Heft: 3, Pages: 371-373
ISSN:1592-8721
DOI:10.3324/%x
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://haematologica.org/article/view/3017
Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3324/%25x
Volltext
Verfasserangaben:Axel Glasmacher, Hartmut Goldschmidt, Jörg Mezger, Torsten Haferlach, Ingo G.H. Schmidt-Wolf, Frank Gieseler

MARC

LEADER 00000caa a2200000 c 4500
001 1793949069
003 DE-627
005 20230427030945.0
007 cr uuu---uuuuu
008 220225s2004 xx |||||o 00| ||eng c
024 7 |a 10.3324/%25x  |2 doi 
035 |a (DE-627)1793949069 
035 |a (DE-599)KXP1793949069 
035 |a (OCoLC)1341445515 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Glasmacher, Axel  |e VerfasserIn  |0 (DE-588)1104849275  |0 (DE-627)862193001  |0 (DE-576)472914553  |4 aut 
245 1 0 |a Oral idarubicin, dexamethasone and vincristine in the treatment of multiple myeloma  |b final analysis of a phase II trial  |c Axel Glasmacher, Hartmut Goldschmidt, Jörg Mezger, Torsten Haferlach, Ingo G.H. Schmidt-Wolf, Frank Gieseler 
264 1 |c 2004 
300 |a 3 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a DOI fehlerhaft 
500 |a Gesehen am 25.02.2022 
520 |a This prospective phase II study evaluated a regimen with vincristine, oral idarubicin and dexamethasone (VID) in 74 patients with multiple myeloma. A partial response was achieved in 57% (16/28) of patients with previously untreated disease and in 35% (16/46) with refractory diseases. VID chemotherapy is an effective and tolerable oral alternative in an outpatient setting for these patients. 
650 4 |a Aged 
650 4 |a Antineoplastic Combined Chemotherapy Protocols 
650 4 |a Dexamethasone 
650 4 |a Female 
650 4 |a Humans 
650 4 |a Idarubicin 
650 4 |a Male 
650 4 |a Middle Aged 
650 4 |a Multiple Myeloma 
650 4 |a Prospective Studies 
650 4 |a Vincristine 
700 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
700 1 |a Mezger, Jörg  |e VerfasserIn  |4 aut 
700 1 |a Haferlach, Torsten  |e VerfasserIn  |4 aut 
700 1 |a Schmidt-Wolf, Ingo G. H.  |e VerfasserIn  |4 aut 
700 1 |a Gieseler, Frank  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Haematologica  |d Pavia : Ferrata Storti Found, 1996  |g 89(2004), 3, Seite 371-373  |h Online-Ressource  |w (DE-627)32474224X  |w (DE-600)2030158-3  |w (DE-576)281198683  |x 1592-8721  |7 nnas  |a Oral idarubicin, dexamethasone and vincristine in the treatment of multiple myeloma final analysis of a phase II trial 
773 1 8 |g volume:89  |g year:2004  |g number:3  |g pages:371-373  |g extent:3  |a Oral idarubicin, dexamethasone and vincristine in the treatment of multiple myeloma final analysis of a phase II trial 
856 4 0 |u https://haematologica.org/article/view/3017  |x Verlag  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://doi.org/10.3324/%25x  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220225 
993 |a Editorial 
994 |a 2004 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |d 50000  |e 910000PG102258023X  |e 910100PG102258023X  |e 50000PG102258023X  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 2 
999 |a KXP-PPN1793949069  |e 4073540297 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"person":[{"role":"aut","given":"Axel","family":"Glasmacher","display":"Glasmacher, Axel"},{"given":"Hartmut","role":"aut","family":"Goldschmidt","display":"Goldschmidt, Hartmut"},{"role":"aut","given":"Jörg","family":"Mezger","display":"Mezger, Jörg"},{"display":"Haferlach, Torsten","family":"Haferlach","role":"aut","given":"Torsten"},{"given":"Ingo G. H.","role":"aut","family":"Schmidt-Wolf","display":"Schmidt-Wolf, Ingo G. H."},{"given":"Frank","role":"aut","family":"Gieseler","display":"Gieseler, Frank"}],"relHost":[{"part":{"year":"2004","pages":"371-373","issue":"3","text":"89(2004), 3, Seite 371-373","volume":"89","extent":"3"},"language":["eng"],"disp":"Oral idarubicin, dexamethasone and vincristine in the treatment of multiple myeloma final analysis of a phase II trialHaematologica","type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"subtitle":"journal of hematology ; official organ for The Italian Society of Hematology, The Italian Society of Experimental Hematology, The Spanish Association of Hematology and Hemotherapy, The Italian Society of Hemostasis and Thrombosis, and The Italian Society of Pediatric, Hematology, Oncology","title_sort":"Haematologica","title":"Haematologica"}],"origin":[{"dateIssuedDisp":"1996-2004","dateIssuedKey":"1996","publisher":"Ferrata Storti Found","publisherPlace":"Pavia"}],"note":["Gesehen am 22.10.07"],"pubHistory":["Nachgewiesen 79.1994 - 89.2004"],"id":{"eki":["32474224X"],"zdb":["2030158-3"],"issn":["1592-8721"]},"recId":"32474224X","physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["founded by Adolfo Ferrata"]}}],"recId":"1793949069","physDesc":[{"extent":"3 S."}],"name":{"displayForm":["Axel Glasmacher, Hartmut Goldschmidt, Jörg Mezger, Torsten Haferlach, Ingo G.H. Schmidt-Wolf, Frank Gieseler"]},"id":{"doi":["10.3324/%25x"],"eki":["1793949069"]},"title":[{"title_sort":"Oral idarubicin, dexamethasone and vincristine in the treatment of multiple myeloma","subtitle":"final analysis of a phase II trial","title":"Oral idarubicin, dexamethasone and vincristine in the treatment of multiple myeloma"}],"note":["DOI fehlerhaft","Gesehen am 25.02.2022"],"origin":[{"dateIssuedKey":"2004","dateIssuedDisp":"2004"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a GLASMACHERORALIDARUB2004 

Ähnliche Einträge